What Is New?
thrombocytopenia, chronic coronary syndrome
THROMBOCYTOPENIA, CHRONIC CORONARY SYNDROME, ATRIAL FIBRILLATION (AF)

Although guidelines currently recommend antithrombotic monotherapy for patients with chronic coronary syndrome (CCS) and atrial fibrillation (AF), whether this recommendation should be extended to patients with thrombocytopenia with CCS and AF remains unclear.This study is the first to demonstrate favorable outcomes of rivaroxaban monotherapy in thrombocytopenia patients with CCS and AF.